Jonathan P. Mow - 19 Nov 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Nov 2021
Net transactions value
+$11,302
Form type
4
Filing time
23 Nov 2021, 17:55:14 UTC
Previous filing
03 Nov 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $11,302 +5,623 +3.4% $2.01* 172,473 19 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).